The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of
cardiotoxicity. It has been calculated that approximately 10% of patients treated with …

Long term survival of childhood cancers is now more than 70%. Anthracyclines, including
doxorubicin, are some of the most efficacious anticancer drugs available. However, its use …

АВ—атриовентрикулярный (ая) АГ—артериальная гипертензия АД—артериальное
давление АТ—артериальный тромбоз АТО—атеротромботические осложнения АТФ …

New antitumor agents have resulted in significant survival benefits for cancer patients.
However, several agents may have serious cardiovascular side effects. Left ventricular …

Doxorubicin (DOX) is a potent chemotherapeutic agent used against several cancer types.
However, due to its cardiotoxic adverse effects, the use of this drug may be also life …

Novel therapeutic options have significantly improved survival and long-term outcomes in
many cancer entities. Unfortunately, this improvement in outcome is often accompanied by …

Cardiotoxicity may present as (pulmonary) hypertension, acute and chronic coronary
syndromes, venous thromboembolism, cardiomyopathies/heart failure, arrhythmia, valvular …

The field of cardio-oncology is challenged to address an ever greater spectrum of
cardiotoxicity associated with combination chemotherapy, greater dose intensity, extremes …

Chemotherapy-induced cardiac toxicity is an undesirable yet very common effect that
increases the risk of death and reduce the quality of life of individuals undergoing …

Imaging of cardiac 18F-FDG uptake is used in the diagnostic evaluation of residual viable
myocardium. Although, originally, hibernating myocardium was identified by a mismatch …